Skip to main content
Erschienen in: Journal of Community Health 2/2008

01.04.2008 | Original Paper

Association of Alcohol Abuse and Injection Drug Use with Immunologic and Virologic Responses to HAART in HIV-positive Patients from Urban Community Health Clinics

verfasst von: Timothy J. Henrich, Naudia Lauder, Mayur M. Desai, Andre N. Sofair

Erschienen in: Journal of Community Health | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study is to examine the association of alcohol abuse and injection drug use (IDU) with the immunologic and virologic responses to highly active antiretroviral treatment (HAART) in urban community health clinics. The medical records of 293 HIV-infected adult patients who visited either of two urban health clinics in New Haven, Connecticut, from June 2003 to December 2004 were retrospectively reviewed. Changes in mean CD4 lymphocyte counts and undetectable viral loads were compared before and after the initiation of HAART for patients categorized into one of four substance abuse groups: history of neither alcohol abuse nor IDU, alcohol abuse only, IDU only, or both. Unadjusted mean improvements in CD4 count for the four groups were 136, 97, 20, and 27, respectively. In a linear regression model adjusted for age, gender, and baseline CD4 count, history of IDU only (P = 0.037) and a combination of alcohol abuse and IDU (P = 0.038) were associated with a lesser increase in CD4 count after HAART compared with those with neither alcohol nor IDU. No significant associations were found between substance abuse history and changes in detectable viral load. Our results show that many patients at urban health clinics have a history of either injection drug use or alcohol abuse, and that injection drug use is negatively associated with the immunologic response to HAART in urban HIV-infected individuals. This study highlights the importance for clinicians of understanding the negative associations of substance abuse with the treatment response of HIV-infected patients at urban health centers.
Literatur
1.
Zurück zum Zitat Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., et al. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. New England Journal of Medicine, 337, 725–733.PubMedCrossRef Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., et al. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. New England Journal of Medicine, 337, 725–733.PubMedCrossRef
2.
Zurück zum Zitat Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., et al. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. Journal of the American Medical Association, 279, 930–937.PubMedCrossRef Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., et al. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. Journal of the American Medical Association, 279, 930–937.PubMedCrossRef
3.
Zurück zum Zitat Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. Aids, 18, S19–S25.PubMedCrossRef Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. Aids, 18, S19–S25.PubMedCrossRef
4.
Zurück zum Zitat Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251–259.PubMed Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251–259.PubMed
5.
Zurück zum Zitat Egea, J. M., Muga, R., Sirera, G., Clotet, B., Tor, J., Ardevol, M., et al. (2002). Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users. Epidemiology and Infection, 129, 325–333.PubMedCrossRef Egea, J. M., Muga, R., Sirera, G., Clotet, B., Tor, J., Ardevol, M., et al. (2002). Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users. Epidemiology and Infection, 129, 325–333.PubMedCrossRef
6.
Zurück zum Zitat Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction, 99, 361–368.PubMedCrossRef Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction, 99, 361–368.PubMedCrossRef
7.
Zurück zum Zitat Mocroft, A., Madge, S., Johnson, A. M., Lazzarin, A., Clumeck, N., Goebel, F. D., et al. (1999). A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival. Journal of Acquired Immune Deficiency Syndromes, 22, 369–378.PubMed Mocroft, A., Madge, S., Johnson, A. M., Lazzarin, A., Clumeck, N., Goebel, F. D., et al. (1999). A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival. Journal of Acquired Immune Deficiency Syndromes, 22, 369–378.PubMed
8.
Zurück zum Zitat Roca, B., Gomez, C. J., & Arnedo, A. (1999). Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy. Journal of Infection, 39, 141–145.PubMedCrossRef Roca, B., Gomez, C. J., & Arnedo, A. (1999). Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy. Journal of Infection, 39, 141–145.PubMedCrossRef
9.
Zurück zum Zitat Bouhnik, A. D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J. P., et al. (2002). Nonadherence among HIV-infected injecting drug users: The impact of social instability. Journal of Acquired Immune Deficiency Syndromes, 31, S149–S153.PubMed Bouhnik, A. D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J. P., et al. (2002). Nonadherence among HIV-infected injecting drug users: The impact of social instability. Journal of Acquired Immune Deficiency Syndromes, 31, S149–S153.PubMed
10.
Zurück zum Zitat Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M., et al. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. American Journal of Drug and Alcohol Abuse, 26, 195–205.PubMedCrossRef Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M., et al. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. American Journal of Drug and Alcohol Abuse, 26, 195–205.PubMedCrossRef
11.
Zurück zum Zitat Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29, 117–127.PubMedCrossRef Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29, 117–127.PubMedCrossRef
12.
Zurück zum Zitat Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381.PubMed Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381.PubMed
13.
Zurück zum Zitat Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114, 573–580.PubMedCrossRef Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114, 573–580.PubMedCrossRef
14.
Zurück zum Zitat Wood, E., Montaner, J. S., Yip, B., Tyndall, M. W., Schechter, M. T., O’Shaughnessy, M. V., et al. (2004). Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antiviral Therapy, 9, 229–235.PubMed Wood, E., Montaner, J. S., Yip, B., Tyndall, M. W., Schechter, M. T., O’Shaughnessy, M. V., et al. (2004). Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antiviral Therapy, 9, 229–235.PubMed
15.
Zurück zum Zitat Zaccarelli, M., Barracchini, A., De Longis, P., Perno, C. F., Soldani, F., Liuzzi, G., et al. (2002). Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine. AIDS Patient Care STDS, 16, 67–73.PubMedCrossRef Zaccarelli, M., Barracchini, A., De Longis, P., Perno, C. F., Soldani, F., Liuzzi, G., et al. (2002). Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine. AIDS Patient Care STDS, 16, 67–73.PubMedCrossRef
16.
Zurück zum Zitat Dragsted, U. B., Mocroft, A., Vella, S., Viard, J. P., Hansen, A. B., Panos, G., et al. (2004). Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: A EuroSIDA study. Journal of Infectious Diseases, 190, 148–155.PubMedCrossRef Dragsted, U. B., Mocroft, A., Vella, S., Viard, J. P., Hansen, A. B., Panos, G., et al. (2004). Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: A EuroSIDA study. Journal of Infectious Diseases, 190, 148–155.PubMedCrossRef
17.
Zurück zum Zitat Palepu, A., Tyndall, M., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2003). Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. Journal of Acquired Immune Deficiency Syndromes, 32, 522–526.PubMedCrossRef Palepu, A., Tyndall, M., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2003). Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. Journal of Acquired Immune Deficiency Syndromes, 32, 522–526.PubMedCrossRef
18.
Zurück zum Zitat Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., & Grant, I. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188, 1820–1826.PubMedCrossRef Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., & Grant, I. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188, 1820–1826.PubMedCrossRef
19.
Zurück zum Zitat Mohammed, H., Kieltyka, L., Richardson-Alston, G., Magnus, M., Fawal, H., Vermund, S. H., et al. (2004). Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS, 18, 289–296.PubMedCrossRef Mohammed, H., Kieltyka, L., Richardson-Alston, G., Magnus, M., Fawal, H., Vermund, S. H., et al. (2004). Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS, 18, 289–296.PubMedCrossRef
20.
Zurück zum Zitat Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism–Clinical and Experimental Research, 28, 572–577.CrossRef Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism–Clinical and Experimental Research, 28, 572–577.CrossRef
21.
Zurück zum Zitat Miguez, M. J., Shor-Posner, G., Morales, G., Rodriguez, A., & Burbano, X. (2003). HIV treatment in drug abusers: Impact of alcohol use. Addiction Biology, 8, 33–37.PubMedCrossRef Miguez, M. J., Shor-Posner, G., Morales, G., Rodriguez, A., & Burbano, X. (2003). HIV treatment in drug abusers: Impact of alcohol use. Addiction Biology, 8, 33–37.PubMedCrossRef
22.
Zurück zum Zitat From the Centers for Disease Control and prevention. (1993). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Journal of the American Medical Association, 269, 460. From the Centers for Disease Control and prevention. (1993). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Journal of the American Medical Association, 269, 460.
23.
Zurück zum Zitat McDavid, K., & McKenna, M. T. (2006). HIV/AIDS risk factor ascertainment: A critical challenge. AIDS Patient Care STDS, 20, 285–292.PubMedCrossRef McDavid, K., & McKenna, M. T. (2006). HIV/AIDS risk factor ascertainment: A critical challenge. AIDS Patient Care STDS, 20, 285–292.PubMedCrossRef
24.
Zurück zum Zitat Moore, A. L., Kirk, O., Johnson, A. M., Katlama, C., Blaxhult, A., Dietrich, M., et al. (2003). Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The gender issue revisited. Journal of Acquired Immune Deficiency Syndromes, 32, 452–461.PubMedCrossRef Moore, A. L., Kirk, O., Johnson, A. M., Katlama, C., Blaxhult, A., Dietrich, M., et al. (2003). Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The gender issue revisited. Journal of Acquired Immune Deficiency Syndromes, 32, 452–461.PubMedCrossRef
25.
Zurück zum Zitat Goodkin, K., Shapshak, P., Asthana, D., Zheng, W., Concha, M., Wilkie, F. L., et al. (2004). Older age and plasma viral load in HIV-1 infection. Aids, 18, S87–S98.PubMedCrossRef Goodkin, K., Shapshak, P., Asthana, D., Zheng, W., Concha, M., Wilkie, F. L., et al. (2004). Older age and plasma viral load in HIV-1 infection. Aids, 18, S87–S98.PubMedCrossRef
26.
Zurück zum Zitat Wagner, G. J., & Ryan, G. W. (2004). Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDS, 18, 385–393.PubMedCrossRef Wagner, G. J., & Ryan, G. W. (2004). Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDS, 18, 385–393.PubMedCrossRef
27.
Zurück zum Zitat Murphy, D. A., Marelich, W. D., Hoffman, D., & Steers, W. N. (2004). Predictors of antiretroviral adherence. AIDS Care, 16, 471–484.PubMedCrossRef Murphy, D. A., Marelich, W. D., Hoffman, D., & Steers, W. N. (2004). Predictors of antiretroviral adherence. AIDS Care, 16, 471–484.PubMedCrossRef
28.
Zurück zum Zitat Turner, B. J., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., Shapiro, M. F., et al. (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625–633.PubMedCrossRef Turner, B. J., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., Shapiro, M. F., et al. (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625–633.PubMedCrossRef
29.
Zurück zum Zitat Cook, J. A., Grey, D., Burke, J., Cohen, M. H., Gurtman, A. C., Richardson, J. L., et al. (2004). Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health, 94, 1133–1140.PubMedCrossRef Cook, J. A., Grey, D., Burke, J., Cohen, M. H., Gurtman, A. C., Richardson, J. L., et al. (2004). Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health, 94, 1133–1140.PubMedCrossRef
30.
Zurück zum Zitat Lehman, A. F., Myers, C. P., Corty, E., & Thompson, J. W. (1994). Prevalence and patterns of “dual diagnosis” among psychiatric inpatients. Comprehensive Psychiatry, 35, 106–112.PubMedCrossRef Lehman, A. F., Myers, C. P., Corty, E., & Thompson, J. W. (1994). Prevalence and patterns of “dual diagnosis” among psychiatric inpatients. Comprehensive Psychiatry, 35, 106–112.PubMedCrossRef
31.
Zurück zum Zitat Powell-Cope, G. M., White, J., Henkelman, E. J., & Turner, B. J. (2003). Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care, 15, 239–249.PubMedCrossRef Powell-Cope, G. M., White, J., Henkelman, E. J., & Turner, B. J. (2003). Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care, 15, 239–249.PubMedCrossRef
32.
Zurück zum Zitat Conway, B., Prasad, J., Reynolds, R., Farley, J., Jones, M., Jutha, S., et al. (2004). Directly observed therapy for the management of HIV-infected patients in a methadone program. Clinical and Infectious Diseases, 38, S402–S408.CrossRef Conway, B., Prasad, J., Reynolds, R., Farley, J., Jones, M., Jutha, S., et al. (2004). Directly observed therapy for the management of HIV-infected patients in a methadone program. Clinical and Infectious Diseases, 38, S402–S408.CrossRef
33.
Zurück zum Zitat Visnegarwala, F., Rodriguez-Barradass, M. C., Graviss, E. A., Caprio, M., Nykyforchyn, M., & Laufman, L. (2006). Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care, 18, 332–338.PubMedCrossRef Visnegarwala, F., Rodriguez-Barradass, M. C., Graviss, E. A., Caprio, M., Nykyforchyn, M., & Laufman, L. (2006). Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care, 18, 332–338.PubMedCrossRef
34.
Zurück zum Zitat Williams, A. B., Fennie, K. P., Bova, C. A., Burgess, J. D., Danvers, K. A., & Dieckhaus, K. D. (2006). Home visits to improve adherence to highly active antiretroviral therapy: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 42, 314–321.PubMedCrossRef Williams, A. B., Fennie, K. P., Bova, C. A., Burgess, J. D., Danvers, K. A., & Dieckhaus, K. D. (2006). Home visits to improve adherence to highly active antiretroviral therapy: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 42, 314–321.PubMedCrossRef
35.
Zurück zum Zitat Frick, P., Tapia, K., Grant, P., Novotny, M., & Kerzee, J. (2006). The effect of a multidisciplinary program on HAART adherence. AIDS Patient Care STDS, 20, 511–524.PubMedCrossRef Frick, P., Tapia, K., Grant, P., Novotny, M., & Kerzee, J. (2006). The effect of a multidisciplinary program on HAART adherence. AIDS Patient Care STDS, 20, 511–524.PubMedCrossRef
36.
Zurück zum Zitat Tuldra, A., & Wu, A. W. (2002). Interventions to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S154–S157.PubMed Tuldra, A., & Wu, A. W. (2002). Interventions to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S154–S157.PubMed
37.
Zurück zum Zitat McNagny, S. E., & Parker, R. M. (1992). High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. Journal of the American Medical Association, 267, 1106–1108.PubMedCrossRef McNagny, S. E., & Parker, R. M. (1992). High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. Journal of the American Medical Association, 267, 1106–1108.PubMedCrossRef
38.
Zurück zum Zitat Moore, R. D., Bone, L. R., Geller, G., Mamon, J. A., Stokes, E. J., & Levine, D. M. (1989). Prevalence, detection, and treatment of alcoholism in hospitalized patients. Journal of the American Medical Association, 261, 403–407.PubMedCrossRef Moore, R. D., Bone, L. R., Geller, G., Mamon, J. A., Stokes, E. J., & Levine, D. M. (1989). Prevalence, detection, and treatment of alcoholism in hospitalized patients. Journal of the American Medical Association, 261, 403–407.PubMedCrossRef
Metadaten
Titel
Association of Alcohol Abuse and Injection Drug Use with Immunologic and Virologic Responses to HAART in HIV-positive Patients from Urban Community Health Clinics
verfasst von
Timothy J. Henrich
Naudia Lauder
Mayur M. Desai
Andre N. Sofair
Publikationsdatum
01.04.2008
Verlag
Springer US
Erschienen in
Journal of Community Health / Ausgabe 2/2008
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-007-9069-1

Weitere Artikel der Ausgabe 2/2008

Journal of Community Health 2/2008 Zur Ausgabe